{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:57:53Z","timestamp":1776837473224,"version":"3.51.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Br. J. Biomed. Sci."],"abstract":"<jats:p>Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by marked molecular heterogeneity and limited targeted therapeutic options. Its incidence is rising in many low- and middle-income countries, where genetic profiling of affected patients remains largely unexplored despite evident clinical disparities. This study aimed to characterize, for the first time in a Tunisian cohort, the spectrum of germline and somatic mutations in TNBC patients and to assess their potential impact on therapeutic response. Targeted next-generation sequencing (NGS) of hotspot regions across 50 cancer-related genes was performed in twelve patients using the AmpliSeq for Illumina Cancer Hotspot Panel v2, applied to both tumor tissues and matched adjacent non-tumoral tissues. Bioinformatics analysis revealed recurrent germline variants present in all samples, notably in TP53 (rs1042522), CSF1R (rs2066933), FGFR3 (rs7688609), RET (rs1800861), KDR (rs7692791), and PDGFRA (rs1873778). In tumor tissues, 32 deleterious somatic variants were detected across 20 oncogenes, with TP53 emerging as the most frequently mutated gene (58%). Distinct mutational patterns were observed in relation to treatment response. Notably, the co-occurrence of AKT1 (rs121434592) and TP53 (rs876660754) was observed in a patient with treatment resistance, whereas an in-frame deletion in NOTCH1 (p.Val1578del) was uniquely detected in patients who subsequently experienced disease recurrence. These findings provide the first comprehensive characterization of germline and somatic alterations in Tunisian TNBC patients, representing a North African cohort. They reveal the heterogeneity of mutation patterns linked to treatment response, and emphasize the importance of genomic profiling into clinical practice and guide personalized therapeutic strategies.<\/jats:p>","DOI":"10.3389\/bjbs.2026.15988","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:10:17Z","timestamp":1776834617000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Somatic and Germline Mutations Influencing Treatment Outcomes and Disease Susceptibility in Tunisian Triple-Negative Breast Cancer Using Next-Generation Sequencing"],"prefix":"10.3389","volume":"83","author":[{"given":"Asma","family":"Mehri","sequence":"first","affiliation":[{"name":"Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]},{"name":"Commun Sequencing Unite, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Baligh","family":"Laaribi","sequence":"additional","affiliation":[{"name":"Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]},{"name":"Commun Sequencing Unite, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichraf","family":"Jbir","sequence":"additional","affiliation":[{"name":"Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]},{"name":"Faculty of Medicine of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]},{"name":"Department of General Surgery, University Hospital of Mohamed Taher Maamouri","place":["Nabeul, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emna","family":"Chelbi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Mohamed Taher Maamouri","place":["Nabeul, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beya","family":"Chelly","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Mohamed Taher Maamouri","place":["Nabeul, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abir","family":"Chaabane","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Mohamed Taher Maamouri","place":["Nabeul, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salwa","family":"Nechi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital of Mohamed Taher Maamouri","place":["Nabeul, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadda-Imen","family":"Ouzari","sequence":"additional","affiliation":[{"name":"Laboratory of Microorganisms and Active Biomolecules (LR03ES03), Faculty of Sciences of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]},{"name":"Commun Sequencing Unite, Department of Biology, Faculty of Sciences of Tunis, University of Tunis El Manar","place":["Tunis, Tunisia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global Patterns and Trends in Breast Cancer Incidence and Mortality Across 185 Countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-Negative Breast Cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3896","article-title":"Triple-Negative Breast Cancer in African-American Women: Disparities Versus Biology","volume":"15","author":"Dietze","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/PPO.0000000000000494","article-title":"Triple-Negative Breast Cancer: Breast Tumors with an Identity Crisis","volume":"27","author":"Nunnery","year":"2021","journal-title":"Cancer J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of Age: Ten Years of Next-Generation Sequencing Technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat Rev Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/annonc\/mdy024","article-title":"Unravelling Triple-Negative Breast Cancer Molecular Heterogeneity Using an Integrative Multiomic Analysis","volume":"29","author":"Bareche","year":"2018","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The Somatic Mutation Profiles of 2,433 Breast Cancers Refine Their Genomic and Transcriptomic Landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer","volume":"33","author":"Couch","year":"2015","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients with Breast Cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.xgen.2024.100724","article-title":"Bridging Genomics' Greatest Challenge: The Diversity Gap","volume":"5","author":"Corpas","year":"2025","journal-title":"Cell Genom"},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/538161a","article-title":"Genomics Is Failing on Diversity","volume":"538","author":"Popejoy","year":"2016","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The Missing Diversity in Human Genetic Studies","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"154514","DOI":"10.1016\/j.prp.2023.154514","article-title":"Multigene Germline Testing Usefulness Instead of BRCA1\/2 Single Screening in Triple Negative Breast Cancer Cases","volume":"247","author":"Arranz-Ledo","year":"2023","journal-title":"Pathol - Res Pract"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1699280","DOI":"10.3389\/fphar.2025.1699280","article-title":"Identification of Novel Germline and Somatic Mutations Associated with Hepatocellular Carcinoma by Next-Generation Sequencing","volume":"16","author":"Laaribi","year":"2026","journal-title":"Front Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"018","DOI":"10.1186\/s12885-9","article-title":"Combining Genomic Analyses with Tumour-Derived Slice Cultures for the Characterization of an EGFR-Activating Kinase Mutation in a Case of Glioblastoma","volume":"18","author":"Loriguet","year":"2018","journal-title":"BMC Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/CBM-210088","article-title":"Discrepancies of RET Gene and Risk of Differentiated Thyroid Carcinoma","volume":"33","author":"Rashid","year":"2022","journal-title":"Cancer Biomark"},{"key":"B18","first-page":"396","article-title":"Epidermal Growth Factor Receptor Pathway Polymorphisms and the Prognosis of Hepatocellular Carcinoma","volume":"5","author":"Wang","year":"2014","journal-title":"Am J Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3892\/ol.2016.4646","article-title":"Investigating Polymorphisms by Bioinformatics Is a Potential Cost-Effective Method to Screen for Germline Mutations in Chinese Familial Adenomatous Polyposis Patients","volume":"12","author":"Yang","year":"2016","journal-title":"Oncol Lett"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3892\/ol.2019.9984","article-title":"Genetic Alterations of Triple Negative Breast Cancer (TNBC) in Women from Northeastern Mexico","volume":"17","author":"Uscanga-Perales","year":"2019","journal-title":"Oncol Lett"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/S0016672315000075","article-title":"Evaluation of the p53 Arg72Pro Polymorphism and Its Association with Cancer Risk: A HuGE Review and Meta-Analysis","volume":"17","author":"Khan","year":"2015","journal-title":"Genet Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng1093","article-title":"The Codon 72 Polymorphic Variants of p53 Have Markedly Different Apoptotic Potential","volume":"33","author":"Dumont","year":"2003","journal-title":"Nat Genet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/jmcb\/mjz052","article-title":"Common Genetic Variants in the TP53 Pathway and Their Impact on Cancer","volume":"11","author":"Barnoud","year":"2019","journal-title":"J Mol Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1101\/gad.309062.117","article-title":"Mutant p53 Controls Tumor Metabolism and Metastasis by Regulating PGC-1\u03b1","volume":"32","author":"Basu","year":"2018","journal-title":"Genes Dev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1272876","DOI":"10.3389\/fonc.2023.1272876","article-title":"TP53 Gene 72 Arg\/Pro (Rs1042522) Single Nucleotide Polymorphism Increases the Risk and the Severity of Chronic Lymphocytic Leukemia","volume":"13","author":"Ounalli","year":"2023","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"116981","DOI":"10.1016\/j.diagmicrobio.2025.116981","article-title":"The TP53 \u201cRs 1042522\u201d Polymorphism and Its Association with Precancerous Cervical Lesions Progression Among Tunisian Women","volume":"113","author":"Ben Jemia","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0141351","DOI":"10.1371\/journal.pone.0141351","article-title":"Altered Gene Expression Associated with Microrna Binding Site Polymorphisms","volume":"10","author":"V\u00f5sa","year":"2015","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"14394","DOI":"10.18632\/oncotarget.7343","article-title":"Retrospective Study Testing next Generation Sequencing of Selected Cancer-Associated Genes in Resected Prostate Cancer","volume":"7","author":"Lo Iacono","year":"2016","journal-title":"Oncotarget"},{"key":"B29","first-page":"7","article-title":"Mutation Profiling of Intracranial Myxopapillary Ependymoma by next Generation DNA Sequencing","volume":"1","author":"Taher","year":"2021","journal-title":"Gulf J Oncolog"},{"key":"B30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/IMCRJ.S243405","article-title":"Adamantinomatous Craniopharyngioma in an Adult: A Case Report with NGS Analysis","volume":"13","author":"Jastania","year":"2020","journal-title":"Int Med Case Rep J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"020","DOI":"10.1186\/s12943-x","article-title":"The Role of Ubiquitination and Deubiquitination in Cancer Metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/cancers12071731","article-title":"Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities","volume":"12","author":"Neitzel","year":"2020","journal-title":"Cancers"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113491","article-title":"Receptor Tyrosine Kinase-Targeted Cancer Therapy","volume":"19","author":"Yamaoka","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"024","DOI":"10.1186\/s12964-9","article-title":"Targeting Mutant p53: A Key Player in Breast Cancer Pathogenesis and Beyond","volume":"22","author":"Qayoom","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/carcin\/bgs232","article-title":"The Rebel Angel: Mutant p53 as the Driving Oncogene in Breast Cancer","volume":"33","author":"Walerych","year":"2012","journal-title":"Carcinogenesis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/s1535-6108(03)00079-5","article-title":"p53 Polymorphism Influences Response in Cancer Chemotherapy via Modulation of p73-Dependent Apoptosis","volume":"3","author":"Bergamaschi","year":"2003","journal-title":"Cancer Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/416560a","article-title":"p63 and p73 Are Required for p53-Dependent Apoptosis in Response to DNA Damage","volume":"416","author":"Flores","year":"2002","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/cdd.2017.185","article-title":"Mutant p53 Partners in Crime","volume":"25","author":"Kim","year":"2018","journal-title":"Cell Death and Differ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1007\/s11030-024-11045-x","article-title":"Small Molecules that Targeting p53 Y220C Protein: Mechanisms, Structures, and Clinical Advances in Anti-Tumor Therapy","volume":"29","author":"Xu","year":"2025","journal-title":"Mol Divers"},{"key":"B40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fcell.2020.573599","article-title":"Effect of AKT1 (P. E17K) Hotspot Mutation on Malignant Tumorigenesis and Prognosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Develop Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s12672-025-03083-0","article-title":"Selective Targeting of the AKT1 (E17K) Mutation: Advances in Precision Oncology and Therapeutic Design","volume":"16","author":"Chen","year":"2025","journal-title":"Discov Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1158\/1078-0432.CCR-14-1348","article-title":"PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a \u03b3-Secretase Inhibitor","volume":"21","author":"Wang","year":"2015","journal-title":"Clin Cancer Res"}],"container-title":["British Journal of Biomedical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2026.15988\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:10:18Z","timestamp":1776834618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/bjbs.2026.15988\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":43,"alternative-id":["10.3389\/bjbs.2026.15988"],"URL":"https:\/\/doi.org\/10.3389\/bjbs.2026.15988","relation":{},"ISSN":["2474-0896"],"issn-type":[{"value":"2474-0896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"15988"}}